Study Finds Abaloparatide Can Stimulate Bone Formation in Osteoporosis

Nancy Lane, MD, discussed her team's study on abaloparatide, a new preparation of a hormone, and how it can stimulate bone formation.

Nancy Lane, MD, discussed her team's study on abaloparatide, a new preparation of a hormone, and how it can stimulate bone formation. Prior studies had shown, Lane said, that 18 months of treatment in pot menopausal women showed significant increase in spine and hip bone density, and reduced both vertebral and non-vertebral fractures. At ACR/ARHP, Lane continued to explain the significance the severity of osteoporosis had on the study. She is optimistic that once the drug gets official clearance, she and her team would know which patient population to use it for.

Related Videos
Brian LaMoreaux, MD | Credit: Horizon Therapeutics
Natalie McCormick, PhD | Credit: American College of Rheumatology
Brian LaMoreaux, MD | Credit: Horizon Therapeutics
Victor Kim, MD: Addressing Comorbidities and Advancing COPD Care
Victor-Kim-MD
Cedric Rutland, MD: Exploring Immunology's Role in Molecule Development
Panagis Galiatsatos, MD: Closing the Gap in Lung Cancer Screening
Related Content
© 2023 MJH Life Sciences

All rights reserved.